GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Polymeric Biomaterials Market, By Product (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethanes, Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK), Polydioxanone (PDO) and Others), By Application (Cardiovascular (Bioresorbable Stents, Vascular Grafts, Sensors, Guidewires, Implantable Cardiac Defibrillators, Pacemakers, and Others), Dental (Tissue Regeneration Materials, Dental Implants, Bone Grafts & Substitutes, Dental Membranes, Dental Sutures and Others), Orthopedic (Joint Replacement Polymeric Biomaterials, Tissue Fixation Products (Suture Anchors and Others), Orthobiologics, Viscosupplementation, Spine Biomaterials and Others), Plastic Surgery (Facial Wrinkle Treatment, Soft Tissue Fillers, Craniofacial Surgery (Sutures and Others), Bioengineered Skins, Peripheral Nerve Repair, Acellular Dermal Matrices and Others), Neurology (Neural Stem Cell Encapsulation, Shunting Systems, Hydrogel Scaffold For CNS Repair, Cortical Neural Prosthetics and Others) and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jan 2024
Code : CMI6533
Pages :170
Formats :
Excel and PDF
Industry : Healthcare IT

Global Polymeric Biomaterials Market Size and Trends

Global polymeric biomaterials market size is expected to reach US$ 121.52 Bn by 2030, from US$ 48.85 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 13.9% during the forecast period.

Global Polymeric Biomaterials Market- Trends

Increased adoption of biodegradable polymers: Increased adoption of biodegradable polymers is having a significant impact on the global polymeric biomaterials market. More companies and consumers are looking for sustainable and eco-friendly options which have boosted the demand for biodegradable polymers in various applications. Biodegradable polymers are derived from renewable plant-based resources thus making them a more viable alternative to conventional plastics which are made from fossil fuels and often end up as plastic waste in the environment. Some of the key biodegradable polymers in demand include polylactic acid (PLA), polyhydroxyalkanoates (PHA), polybutylene succinate (PBS) and biopolyesters. These polymers can degrade in compost or ambient conditions within a span of months without leaving any toxic residues. Products made from biodegradable polymers include bioplastics, medical implants, tissue engineering scaffolds, drug delivery devices and others. The medical industry has especially warmed up to the usage of biodegradable polymeric biomaterials for resorbable surgical devices and implants. For example, PLA is commonly used to make dissolvable stitches and bone fixation devices that naturally degrade and dissolve in the body after conducting their functions.
Customizability of biomaterial properties: The ability to custom design biomaterials with tailored properties at a molecular level has opened up new possibilities and is driving significant innovation in the global polymeric biomaterials market. With advanced material engineering and synthesis techniques, researchers and manufacturers have unprecedented control over biomaterial characteristics such as biodegradability, mechanical integrity, surface properties, and interaction with surrounding physiological environments. This allows them to precisely match material performance with a wide range of clinical application requirements. Polymeric biomaterials can be designed by using complex algorithms that optimize macromolecular structures for specific use cases. For example, a material intended for bone regeneration may need to gradually degrade and transfer stress load in growing tissue, while one used as a scaffold for neuronal growth should have attributes that closely mimic the natural extracellular matrix and promote cell adhesion. The trend towards customizability is empowering researchers to develop new biomaterial formulations with human tissues and organs in mind. Major companies are investing heavily in R&D to come up with cutting-edge polymers that can be customized for diverse medical specialties such as orthopedics, neurology, vascular grafts, and soft tissue repair.